Neurogene

Public

New York City, New YorkBiotechhttps://www.neurogene.com

Last Round

PIPE

Nov 4, 2024

Total Funding Raised

$478.5M

Company Overview

Neurogene is a biotechnology company focused on developing gene therapy solutions that leverage its EXACT gene regulation technology to transform complex neurological diseases into manageable conditions.

Sector

Biotech

AI Layer

Non-AI

Keywords

AAV-based gene therapy for rare neurological diseaseEXACT transgene regulation platformgene therapy for Rett syndromeone-time curative gene therapyin-house gene therapy manufacturingMECP2 gene therapygene therapy for CLN5 Batten diseaseclinical-stage gene therapy companyAAV9 gene therapypediatric neurodegenerative disorder treatmentbiotechnology intellectual property licensing

Neurogene Comps

Public and private peers based on sector, stage, and business model.

Neurogene comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neurogene Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
PIPE	Nov 4, 2024
Private Placement	Dec 19, 2023
Series B	Dec 16, 2020
Series A	Feb 12, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Stuart Cobb

Chief Scientific Officer

Executive Team

Neurogene Investors

Notable investors and investment history

Neurogene investors
Investor	Rounds
EcoR1 Capital	Private Placement, PIPE, Series A, Series B
Redmile Group	Series B, Private Placement, PIPE, Series A
Janus Henderson Group	Series B, Private Placement
Avidity Partners	Series B, Private Placement
Commodore Capital	PIPE
ArrowMark Partners	Series B, Private Placement
Casdin Capital	Series B, Private Placement, PIPE

View all Investors

Neurogene Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Neurogene Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersNew York City, New York

Employee Range134

Year Founded2001

Last FundingNov 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.